Cardioline, a leader in cardiac diagnostics and telecardiology, has announced the acquisition of Cardios, a Brazil-based innovator in Holter monitoring and ambulatory blood pressure monitoring (ABPM), from Halma. Supported by ARCHIMED, this move accelerates Cardioline’s global strategy to provide connected, patient-centered cardiac solutions.
1. Creating a Comprehensive Diagnostic Pathway
The acquisition brings together complementary strengths to cover the full spectrum of cardiac care:
-
Cardioline: Contributes an extensive global reach and a broad portfolio of connected diagnostic tools and telecardiology services.
-
Cardios: Provides decades of specialized clinical expertise and a strong reputation for reliability in Holter and ABPM technologies.
2. Strategic Vision: Integration and Global Impact
The combined entity is positioned to redefine cardiac diagnostic standards through:
-
End-to-End Solutions: Delivering an integrated suite of tools that supports physicians at every step of the cardiac care pathway.
-
Advanced Telecardiology: Leveraging specialized technologies to enhance remote monitoring and diagnostic accuracy for healthcare institutions worldwide.
3. Leadership Perspectives
Luis Meireles, CEO of Cardioline, stated: “Cardios’s deep expertise in Holter and ABPM is the perfect complement to our global portfolio. Together, we are creating a truly end-to-end solution that powers better cardiac care globally.”
Erica Chriguer of Cardios added that by combining their market proximity and clinical reliability with Cardioline’s reach, they aim to generate a positive, lasting impact for both healthcare providers and patients.
Source: https://www.contractpharma.com/breaking-news/cardioline-acquires-cardios/